News
22h
ScienceAlert on MSNScientists Finally Uncovered Where Gluten Reactions StartFor roughly one in every hundred people, food containing even the smallest amounts of gluten can deliver a gutful of hurt and ...
Eating gluten may worsen eczema symptoms in people with a gluten-related disorder, such as celiac disease. However, more research is needed to fully understand the link between gluten and eczema ...
Children with celiac disease have a 19% higher risk of developing mental health problems than others. Gut-brain axis ...
Those afflicted often experience gastrointestinal symptoms like stomach pain, bloating, constipation, gas and diarrhea. But ...
Crohn’s disease and celiac disease are both gastrointestinal (GI) conditions that can cause abdominal pain, diarrhea, and other symptoms. While both diseases cause inflammation in the GI tract ...
- Zinc supplementation in children aged 6 months to 12 years makes little to no difference to all-cause mortality and probably makes no difference to deaths from diarrea. Zinc supplementation probably ...
Buckwheat is a gluten-free pseudo-cereal rich in proteins, fibre and bioactives like rutin. It helps manage celiac disease, ...
MONDAY, June 23, 2025 (HealthDay News) -- Gluten-stimulated interleukin-2 (IL-2) secretion is useful for diagnosis of celiac disease (CeD), according to a study published online June 9 in ...
Hosted on MSN15d
Gluten-Stimulated Interleukin-2 Secretion Useful for Diagnosing Celiac Disease - MSNMONDAY, June 23, 2025 (HealthDay News) -- Gluten-stimulated interleukin-2 (IL-2) secretion is useful for diagnosis of celiac disease (CeD), according to a study published online June 9 in ...
The FB102-101 Phase 1b celiac disease study enrolled 32 subjects 3:1 randomized (24 on FB102 and 8 on placebo). Subjects received 4 doses of FB102 (10 mg/kg) and underwent a 16 day gluten challenge.
be Well: Celiac disease We spoke to a doctor from Greenwich Hospital about celiac disease and how it’s diagnosed. News 12 Staff • Jun 23, 2025, 8:15 AM ...
Forte Biosciences, Inc. ( www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced positive data from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results